NFSG
AGRX

Newbridge Financial Services Group’s Agile Therapeutics AGRX Stock Holding History

Newbridge Financial Services Group’s Portfolio AGRX Stock Details AGRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1
Closed -$3K – 1172
2020
Q3 		$3K Buy
+1
New +$5.73K ﹤0.01% 897

Other funds holding AGRX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FMBTD
First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Newbridge Financial Services Group's AGRX Position: Q4 2020 in Review

Newbridge Financial Services Group sold out of Agile Therapeutics (AGRX) in Q4 2020, closing a stake of 1 share — an estimated $3K sold.

Newbridge Financial Services Group first reported a position in AGRX in Q3 2020 and held it in 1 quarter. The position peaked at $3K in Q3 2020. 76 funds tracked by Wall St. Rank hold AGRX as of Q4 2020.

  • Newbridge Financial Services Group reported no remaining Agile Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Newbridge Financial Services Group sold 1 Agile Therapeutics share in Q4 2020, an estimated $3K.
  • Newbridge Financial Services Group first reported a position in Agile Therapeutics in Q3 2020 and held it in 1 quarter.
  • Newbridge Financial Services Group's Agile Therapeutics position peaked at $3K in Q3 2020.
  • 76 funds tracked by Wall St. Rank held Agile Therapeutics as of Q4 2020.

Based on Newbridge Financial Services Group's 13F filing for Q4 2020, filed 7 Sep 2021.